Early administration of nirmatrelvir/ritonavir leads to faster negative SARS-CoV-2 nasal swabs than monoclonal antibodies in COVID 19 patients at high-risk for severe disease

被引：0

作者：

Marta Colaneri

Giovanni Scaglione

Federico Fassio

Lucia Galli

Alessia Lai

Annalisa Bergna

Arianna Gabrieli

Maciej Tarkowski

Carla Della Ventura

Valeria Colombo

Laura Cordier

Davide Bernasconi

Mario Corbellino

Gianfranco Dedivitiis

Silvia Borghetti

Debora Visigalli

Salvatore Sollima

Giacomo Casalini

Giuliano Rizzardini

Andrea Gori

Spinello Antinori

Agostino Riva

Monica Schiavini

机构：

[1] L. Sacco Hospital,Department of Infectious Diseases, Unit II

[2] ASST Fatebenefratelli Sacco,Department of Public Health, Experimental and Forensic Medicine, Unit of Biostatistics and Clinical Epidemiology

[3] University of Pavia,Department of Biomedical and Clinical Sciences

[4] University of Milan,Department of Infectious Diseases, Unit I

[5] L. Sacco Hospital,Institute of Infectious Diseases & Tropical Medicine, III Division

[6] ASST Fatebenefratelli Sacco,Pharmacy Unit

[7] ASST Fatebenefratelli Sacco,Centre for Multidisciplinary Research in Health Science (MACH)

[8] Luigi Sacco Hospital,undefined

[9] ASST Fatebenefratelli Sacco,undefined

[10] Luigi Sacco Hospital,undefined

[11] University of Milan,undefined

来源：

Virology Journal | / 21卷

关键词：

COVID-19; Monoclonal antibodies; Time to negativization; Immunosuppression; Nirmatrelvir/Ritonavir;

D O I：

暂无

中图分类号：

学科分类号：

摘要：

引用